Imaging of Pancreatic Neoplasms

Eric P. Tamm

doi:10.1016/j.soc.2014.07.002

Imaging of Pancreatic Neoplasms

Eric P. Tamm

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

Abstract

Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery. Imaging has a crucial role in the identification of the primary tumor, vascular variants, identification of metastases, disease response assessment to treatment, and prediction of respectability. Pancreatic neuroendocrine neoplasms can have a distinctive appearance and pattern of spread, which should be recognized on imaging for appropriate management of these patients.

Original language	English (US)
Pages (from-to)	751-788
Number of pages	38
Journal	Surgical oncology clinics of North America
Volume	23
Issue number	4
DOIs	https://doi.org/10.1016/j.soc.2014.07.002
State	Published - Oct 1 2014

Keywords

Cystic pancreatic neoplasms
Imaging
Pancreatic adenocarcinoma
Pancreatic neoplasms
Pancreatic neuroendocrine neoplasms
Radiology

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/j.soc.2014.07.002

Cite this

@article{82f78a83845d4847b59feced56724038,

title = "Imaging of Pancreatic Neoplasms",

abstract = "Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery. Imaging has a crucial role in the identification of the primary tumor, vascular variants, identification of metastases, disease response assessment to treatment, and prediction of respectability. Pancreatic neuroendocrine neoplasms can have a distinctive appearance and pattern of spread, which should be recognized on imaging for appropriate management of these patients.",

keywords = "Cystic pancreatic neoplasms, Imaging, Pancreatic adenocarcinoma, Pancreatic neoplasms, Pancreatic neuroendocrine neoplasms, Radiology",

author = "Tamm, {Eric P.}",

note = "Publisher Copyright: {\textcopyright} 2014 Elsevier Inc.",

year = "2014",

month = oct,

day = "1",

doi = "10.1016/j.soc.2014.07.002",

language = "English (US)",

volume = "23",

pages = "751--788",

journal = "Surgical oncology clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Imaging of Pancreatic Neoplasms

AU - Tamm, Eric P.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery. Imaging has a crucial role in the identification of the primary tumor, vascular variants, identification of metastases, disease response assessment to treatment, and prediction of respectability. Pancreatic neuroendocrine neoplasms can have a distinctive appearance and pattern of spread, which should be recognized on imaging for appropriate management of these patients.

AB - Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery. Imaging has a crucial role in the identification of the primary tumor, vascular variants, identification of metastases, disease response assessment to treatment, and prediction of respectability. Pancreatic neuroendocrine neoplasms can have a distinctive appearance and pattern of spread, which should be recognized on imaging for appropriate management of these patients.

KW - Cystic pancreatic neoplasms

KW - Imaging

KW - Pancreatic adenocarcinoma

KW - Pancreatic neoplasms

KW - Pancreatic neuroendocrine neoplasms

KW - Radiology

UR - http://www.scopus.com/inward/record.url?scp=84907659404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907659404&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2014.07.002

DO - 10.1016/j.soc.2014.07.002

M3 - Review article

C2 - 25246049

AN - SCOPUS:84907659404

SN - 1055-3207

VL - 23

SP - 751

EP - 788

JO - Surgical oncology clinics of North America

JF - Surgical oncology clinics of North America

IS - 4

ER -

Imaging of Pancreatic Neoplasms

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this